Two stocks in Medical Instruments & Supplies
Gerresheimer vs Ypsomed Holding: profit, growth, debt and price compared
Ypsomed Holding is stronger on 4 of 6 figures: profit margin, debt, analysts' view and price trend. Gerresheimer is stronger on 2: sales growth and price for its expected profit.
Save both stocks to your watchlist and revisit their latest fundamentals.
| GerresheimerGXI.DE | Ypsomed HoldingYPSN.SW | |
|---|---|---|
| Net margin | −17.5% | Stronger: 30.4% |
| Revenue growth, past year | Stronger: −0.80% | −13.30% |
| Debt to equity | 236.7% | Stronger: 34.9% |
| Forward P/E | Stronger: 13.5× | 28.8× |
| Dividend yield | — | 1.04% |
| Analysts | Hold · 12 | Stronger: Buy · 14 |
| From its 200-day average | +13.7% | Stronger: +21.2% |
Share price over the past year
- Gerresheimer+40.9%
- Ypsomed Holding+34.9%
20 Nov 202518 Nov 2026
Gerresheimer or Ypsomed Holding: which is stronger?
- YPSN.SW
Which is more profitable?
Ypsomed Holding keeps more of each sale as profit: 30.4% against −17.5%.
- GXI.DE
Which is growing its sales faster?
Gerresheimer is growing its sales faster: −0.80% over the past year, against −13.30%.
- YPSN.SW
Which has borrowed less?
Ypsomed Holding has borrowed less: its debt is 34.9% of what its shareholders own, against 236.7% for Gerresheimer.
- GXI.DE
Which costs less for the profit it is expected to make?
Gerresheimer costs less for the profit it is expected to make: 13.5× its forward earnings, against 28.8×.
Which pays more in dividends?
Ypsomed Holding pays 1.04% a year in dividends for what a share costs, where Gerresheimer pays none.
- YPSN.SW
Which do analysts rate higher?
Analysts are warmer on Ypsomed Holding: Buy, against Hold for Gerresheimer.
- YPSN.SW
Which is in the stronger price trend?
Ypsomed Holding's price is in the stronger trend: 21.2% above its 200-day average, against 13.7% above.
What each company does
GXI.DEGerresheimer
Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally.
Reports results on 25 November 2026
YPSN.SWYpsomed Holding
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
Reports results on 19 May 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.